Bladder Cancer Archives - Page 25 of 37 - Cancer Therapy Advisor

Bladder Cancer

OPDIVO (nivolumab) for Urothelial Carcinoma

This slideshow reviews drug information for OPDIVO (nivolumab), indicated for urothelial carcinoma. Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 12: Use in Specific PopulationsSlide 15: Clinical PharmacologySlide 20: Warnings and PrecautionsSlide 32: Clinical Safety and EfficacySlide 41: Drug Storage and SupplySlide 44: References

Next post in Bladder Cancer